Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

Moderna

Status: Completed

Conditions: Coronavirus Disease (COVID-19)

Treatments: Biological: COVID-19 Vaccine

Study type: Observational

Funder types: Industry

Identifiers

NCT04941144

jRCT2031210168 (Registry Identifier)

mRNA-1273-P918

Details and patient eligibility

About

This study is a long-term follow-up survey of Japanese people after their second vaccination with the Moderna COVID-19 vaccine.

The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study.

The main aim of the study is to check for long-term side effects of the COVID-19 vaccine. This will be from 28 days to 12 months after the second vaccination of the COVID-19 vaccine.

The number of visits to the clinic will depend on the clinic's standard practice.

Enrollment: 8,538 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Participants who have participated in the preceding cohort study and has subsequently provided written consent to participate in this study.

Exclusion criteria

None

Trial design

8,538 participants in 1 patient group

COVID-19 Vaccine Intramuscular Injection 0.5 milliliters (mL)

Description:

COVID-19 vaccine intramuscular injection, 2 doses of 0.5 mL per dose administered intramuscularly at an interval of 4 weeks.

Treatment:

Biological: COVID-19 Vaccine